ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,349,000 | -18.5% | 950,129 | +0.5% | 0.00% | 0.0% |
Q3 2016 | $1,655,000 | +2.2% | 945,725 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $1,620,000 | -1.7% | 947,551 | +13.3% | 0.00% | 0.0% |
Q1 2016 | $1,648,000 | +6.6% | 836,603 | +2.8% | 0.00% | 0.0% |
Q4 2015 | $1,546,000 | -0.8% | 813,789 | -0.3% | 0.00% | 0.0% |
Q3 2015 | $1,558,000 | -59.1% | 815,877 | -0.6% | 0.00% | -60.0% |
Q2 2015 | $3,807,000 | +30.4% | 820,461 | +22.8% | 0.01% | +25.0% |
Q1 2015 | $2,920,000 | +40.2% | 668,239 | +11.4% | 0.00% | +33.3% |
Q4 2014 | $2,082,000 | -17.8% | 599,904 | -0.8% | 0.00% | -25.0% |
Q3 2014 | $2,533,000 | -28.1% | 604,639 | +0.6% | 0.00% | -20.0% |
Q2 2014 | $3,523,000 | -9.6% | 601,165 | -2.9% | 0.01% | -16.7% |
Q1 2014 | $3,899,000 | +8.3% | 618,938 | +0.5% | 0.01% | +20.0% |
Q4 2013 | $3,601,000 | +8.3% | 615,624 | -2.5% | 0.01% | 0.0% |
Q3 2013 | $3,326,000 | -27.8% | 631,159 | +5.5% | 0.01% | -37.5% |
Q2 2013 | $4,608,000 | – | 598,385 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |